Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors-Reference-Cited by-同舟云学术

Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors

Published:2022-06 Issue:3 Volume:46 Page:100859
ISSN:0147-0272
Container-title:Current Problems in Cancer
language:en
Short-container-title:Current Problems in Cancer

Author:

Gharib Khalil El^ORCID,Macaron Walid,Kattan Joseph,Salloum Mohamad Ali,Farhat Fadi,Smith Marianne,Karak Fadi El

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference17 articles.

1. Clinical features, diagnosis, and staging of newly diagnosed breast cancer - UpToDate [Internet], 2020. [cited 2021 Apr 3]. Available at: https://ezproxy.usj.edu.lb:2057/contents/clinical-features-diagnosis-and-staging-of-newly-diagnosed-breast-cancer?search=breast%20cancer&source=search_result&selectedTitle=2∼150&usage_type=default&display_rank=2

2. Comparative effectiveness of first-line palbociclib plus letrozole vs letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice;DeMichele;Breast Cancer Res,2021

3. Treatment patterns and outcomes associated with palbociclib plus letrozole for postmenopausal women with HR+/HER2− advanced breast cancer enrolled in an expanded access program;Brufsky;Clinical Breast Cancer,2019

4. Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases;Turner;Annals of Oncology,2018

5. Palbociclib and Letrozole in Advanced Breast Cancer;Finn;N Engl J Med,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors;Frontiers in Oncology;2023-07-14

2. Modeling breast cancer proliferation, drug synergies, and alternating therapies;iScience;2023-05

3. Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review;Targeted Oncology;2023-04-19

4. Prognostic Parameters of Palbociclib in HR+/HER2- Advanced Breast Cancer: A Narrative Review;Technology in Cancer Research & Treatment;2023-01

5. Modeling Breast Cancer Proliferation, Drug Synergies, and Alternating Therapies;2022-09-22